#Switzerland #pharmaceuticals #Basel #Jungbunzlauer #Tricalcium Citrate

Jungbunzlauer's Tricalcium Citrate and Its Groundbreaking Performance

In an exciting development for the pharmaceutical and nutraceutical industries, Jungbunzlauer, a leading global provider of sustainable ingredients, has unveiled groundbreaking results from a direct compression study involving their Tricalcium Citrate (TCC TB). Conducted in collaboration with Professor Karl Wagner from the University of Bonn, this research showcases how TCC TB can set new performance benchmarks in tablet manufacturing, addressing the diverse challenges presented by complex formulations.

Innovation Rooted in Science

Markus Gerhart, the Senior Director of Lead Minerals Solutions at Jungbunzlauer, emphasized the significance of this collaborative study in affirming the company's commitment to rigorous scientific research, innovation, and product excellence. He stated, "Through validated research, we proudly demonstrate that our TCC TB offers reliable performance in direct compression, enabling our customers to achieve efficiency, quality, and confidence."

The study confirms the rising popularity of direct compression, particularly for its efficiency and suitability for sensitive ingredients. However, this method requires excipients to have exceptional flowability and compactability. The results showcased that TCC TB excels in these areas, providing robust tablet resistance even under low compression force while ensuring rapid disintegration — a critical requirement for demanding formulations, including mini-tablets and moisture-sensitive active ingredients.

The Composition of Excellence

TCC TB is produced through the complete neutralization of citric acid with a high-purity calcium source. This excipient is not only vegan but also allergen-free and non-GMO, fulfilling the stringent standards set by the USP, FCC, and EU.

The outcomes of this pivotal study will be presented at the CPHI Global conference, taking place from October 28 to 30, 2025, at Messe Frankfurt, Hall 8, Stand Q55. Attendees are encouraged to engage with Jungbunzlauer to delve deeper into the data and explore how TCC TB can seamlessly integrate into their next formulation challenge.

About Jungbunzlauer

As a premier manufacturer of sustainable, high-quality ingredients sourced from natural supplies, Jungbunzlauer serves multiple industries, including food and beverage, nutrition, health care, and personal care. Their commitment to developing naturally superior ingredients enhances everyday life, establishing them as a trusted partner with a diverse portfolio of texturants, acidifiers, sweeteners, minerals, and tailored solutions designed to meet the evolving needs of clients.

Headquartered in Basel, Switzerland, Jungbunzlauer operates cutting-edge facilities featuring large-scale fermentation processes in Europe and North America. Over its more than 150-year history, the company has become a major player with a revenue of 1.3 billion Swiss francs and nearly 1,400 dedicated employees committed to a healthier and more sustainable future. For more information about Jungbunzlauer and its innovative products, visit jungbunzlauer.com.